CX 2024 venous programme has “a lot to look forward to,” says executive board
Erin Murphy (Atrium Health’s Sanger Heart and Vascular Institute, Charlotte, USA), one of the CX Symposium cochairs and a CX Executive Board member, along...
CX 2024: Dive into the Venous and Lymphatic Podium Firsts
Manj Gohel (Cambridge, UK), member of the Venous Executive Board, parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM...
In the making: Data-driven venous care
The quest for more data—specifically multicenter, independently adjudicated and, where possible, randomized—in the field of venous disease continues, with various trials currently underway set...
“I still consider myself a student of leadership”: Retired Army General shares lessons on...
“Expect—and prepare for—the unexpected,” Karen Gibson, Sergeant at Arms at the United States Senate, told the UIP 2023 World Congress (Sept. 17–21) during a...
